Open AccessEfficacy of ketamine therapy in the treatment of depression
Author(s) -
Suprio Mandal,
Vinod Kumar Sinha,
Nishant Goyal
Publication year - 2019
Publication title -
indian journal of psychiatry/indian journal of psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.485
H-Index - 34
eISSN - 1998-3794
pISSN - 0019-5545
DOI - 10.4103/psychiatry.indianjpsychiatry_484_18
Subject(s) - ketamine , ketamine hydrochloride , medicine , depression (economics) , anxiety , anesthesia , adverse effect , pharmacotherapy , major depressive disorder , psychiatry , cognition , economics , macroeconomics
Severe depressive disorder is among most debilitating condition. Conventional pharmacotherapy usually takes several weeks (usually 4-12 weeks) to improve symptoms. Ketamine is an N-methyl-D aspartate receptor antagonist having rapid action on depressive symptoms.